GOSS vs. IMRX

Last updated Jun 4, 2026

GOSS (Gossamer Bio, Inc.) and IMRX (Immuneering Corporation) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, GOSS returned -47.62%/yr vs -19.59%/yr for IMRX. At a 0.17 correlation, their price movements are largely independent.

Performance

GOSS vs. IMRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Gossamer Bio, Inc. (GOSS) and Immuneering Corporation (IMRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, GOSS achieves a -93.93% return, which is significantly lower than IMRX's -30.85% return.

GOSS

• 1D: -5.94%
• 1M: -46.26%
• YTD: -93.93%
• 6M: -94.49%
• 1Y: -84.57%
• 3Y*: -47.62%
• 5Y*: -53.34%
• 10Y*: —

IMRX

• 1D: 6.31%
• 1M: -15.51%
• YTD: -30.85%
• 6M: -32.49%
• 1Y: 132.14%
• 3Y*: -19.59%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GOSS vs. IMRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
GOSS Gossamer Bio, Inc.	-93.93%	242.69%	-0.87%	-57.95%	-80.81%	43.89%
IMRX Immuneering Corporation	-30.85%	199.09%	-70.07%	51.55%	-70.01%	-8.07%

Correlation

The correlation between GOSS and IMRX is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (3Y) Calculated over the trailing 3-year period	0.15
Correlation (All Time) Calculated using the full available price history since Aug 2, 2021	0.17

Fundamentals

Market Cap GOSS : $44.09M IMRX : $294.20M
EPS GOSS : -$0.79 IMRX : -$293.00
Total Revenue (TTM) GOSS : $55.54M IMRX : $0.00
Gross Profit (TTM) GOSS : $38.36M IMRX : -$698.89K
EBITDA (TTM) GOSS : -$171.46M IMRX : -$15.38B

Return for Risk

GOSS vs. IMRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GOSS

GOSS Risk / Return Rank: 12
GOSS Sharpe Ratio Rank: 13
GOSS Sortino Ratio Rank: 20
GOSS Omega Ratio Rank: 18
GOSS Calmar Ratio Rank: 6
GOSS Martin Ratio Rank: 3

IMRX

IMRX Risk / Return Rank: 76
IMRX Sharpe Ratio Rank: 73
IMRX Sortino Ratio Rank: 77
IMRX Omega Ratio Rank: 81
IMRX Calmar Ratio Rank: 78
IMRX Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GOSS vs. IMRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Gossamer Bio, Inc. (GOSS) and Immuneering Corporation (IMRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GOSS	IMRX	Difference
Sharpe ratio Return per unit of total volatility	-0.66	1.07	-1.73
Sortino ratio Return per unit of downside risk	-0.47	2.16	-2.64
Omega ratio Gain probability vs. loss probability	0.92	1.31	-0.39
Calmar ratio Return relative to maximum drawdown	-0.89	2.40	-3.29
Martin ratio Return relative to average drawdown	-1.65	3.98	-5.63
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GOSS vs. IMRX - Sharpe Ratio Comparison

The current GOSS Sharpe Ratio is -0.66, which is lower than the IMRX Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of GOSS and IMRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	GOSS	IMRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.66	1.07	-1.73
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.52	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.50	-0.21	-0.28

Drawdowns

GOSS vs. IMRX - Drawdown Comparison

The maximum GOSS drawdown since its inception was -99.30%, roughly equal to the maximum IMRX drawdown of -96.86%. Use the drawdown chart below to compare losses from any high point for GOSS and IMRX.

Drawdown Indicators

	GOSS	IMRX	Difference
Max Drawdown Largest peak-to-trough decline	-99.30%	-96.86%	-2.44%
Max Drawdown (1Y) Largest decline over 1 year	-95.03%	-55.35%	-39.68%
Max Drawdown (3Y) Largest decline over 3 years	-95.03%	-90.98%	-4.05%
Max Drawdown (5Y) Largest decline over 5 years	-98.73%	—	—
Current Drawdown Current decline from peak	-99.30%	-86.14%	-13.16%
Average Drawdown Average peak-to-trough decline	-71.38%	-77.60%	+6.22%
Ulcer Index Depth and duration of drawdowns from previous peaks	51.26%	33.32%	+17.94%

Volatility

GOSS vs. IMRX - Volatility Comparison

Gossamer Bio, Inc. (GOSS) has a higher volatility of 62.06% compared to Immuneering Corporation (IMRX) at 32.23%. This indicates that GOSS's price experiences larger fluctuations and is considered to be riskier than IMRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GOSS	IMRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	62.06%	32.23%	+29.83%
Volatility (6M) Calculated over the trailing 6-month period	182.68%	78.61%	+104.07%
Volatility (1Y) Calculated over the trailing 1-year period	129.41%	123.87%	+5.54%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	103.05%	114.62%	-11.57%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	93.59%	114.62%	-21.03%

Dividends

GOSS vs. IMRX - Dividend Comparison

Neither GOSS nor IMRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both GOSS and IMRX in my portfolio?

GOSS and IMRX have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, GOSS or IMRX?

GOSS has higher volatility (62.06%) compared to IMRX (32.23%). In terms of maximum drawdown, GOSS dropped -99.30% vs IMRX's -96.86%.

Which has better risk-adjusted returns?

IMRX currently has the higher Sharpe Ratio (1.07 vs -0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.